Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Current Medical Research and Opinion|November 27, 2008
Descriptive epidemiology of hospitalisation for psoriasisPete Conway, Craig J CurriePharmacoeconomics|April 6, 2004
Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UKAlan Lenox-Smith, Pete Conway, Chris KnightCurrent Medical Research and Opinion|October 3, 2007
An evaluation of the association between systemic inflammation--as measured by C-reactive protein--and hospital resource useChris D Poole, Pete Conway, Craig J CurrieEuropean Journal of Pain (London, England)|May 31, 2011
The relationship between self-reported severe pain and measures of socio-economic disadvantageChristopher Ll Morgan, Pete Conway, Craig J CurrieClinical Therapeutics|December 22, 2005
Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United KingdomPhil McEwan, Keshwar Baboolal, Pete Conway, et al.BMC Musculoskeletal Disorders|November 6, 2008
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational studyChris D Poole, Pete Conway, Alan Reynolds, et al.Pharmacoeconomics|February 1, 2006
Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UKPhil McEwan, Simon Dixon, Keshwar Baboolal, et al.Current Medical Research and Opinion|November 26, 2005
Characterisation and comparison of health-related quality of life for patients with renal failureAmanda J Lee, Christopher Ll Morgan, Pete Conway, et al.Current Medical Research and Opinion|November 26, 2005
Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 yearsPhil McEwan, Keshwar Baboolal, Simon Dixon, et al.Journal of Medical Economics|February 28, 2012
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphineRobert Ikenberg, Nadine Hertel, R Andrew Moore, et al.Pageof 2